Suchergebnisse
Is WisdomTree India Earnings ETF (EPI) a Strong ETF Right Now?
Making its debut on 02/22/2008, smart beta exchange traded fund WisdomTree India Earnings ETF (EPI) provides investors broad exposure to the Asia-Pacific (Emerging) ETFs category of the market.
Should State Street SPDR Portfolio S&P 500 ETF (SPYM) Be on Your Investing Radar?
If you're interested in broad exposure to the Large Cap Blend segment of the US equity market, look no further than the State Street SPDR Portfolio S&P 500 ETF (SPYM), a passively managed exchange
Should JPMorgan Diversified Return U.S. Equity ETF (JPUS) Be on Your Investing Radar?
Looking for broad exposure to the Large Cap Blend segment of the US equity market? You should consider the JPMorgan Diversified Return U.S. Equity ETF (JPUS), a passively managed exchange traded
Should First Trust Morningstar Dividend Leaders ETF (FDL) Be on Your Investing Radar?
Launched on March 9, 2006, the First Trust Morningstar Dividend Leaders ETF (FDL) is a passively managed exchange traded fund designed to provide a broad exposure to the Large Cap Value segment of
Enpro Q2 Earnings Call Highlights
Key Points
- Interested in Enpro Inc.? Here are five stocks we like better.
- Strong second-quarter performance: Sales rose 17.6% year over year to $338.8 million, while adjusted EBITDA increased
NewJersey Resources Q3 Earnings Call Highlights
Key Points
- Interested in NewJersey Resources Corporation? Here are five stocks we like better.
- NJR raised and narrowed its fiscal 2026 earnings guidance to $3.52–$3.62 per share, citing
NGL Energy Partners Q1 Earnings Call Highlights
Key Points
- Interested in NGL Energy Partners LP? Here are five stocks we like better.
- NGL Energy Partners reported a strong fiscal Q1 2027: Consolidated adjusted EBITDA rose nearly 30% year
Metallus Q2 Earnings Call Highlights
Key Points
- Interested in Metallus Inc.? Here are five stocks we like better.
- Metallus delivered stronger Q2 results: Sales rose 12% year over year to $341 million, while adjusted EBITDA
Millrose Properties Q2 Earnings Call Highlights
Key Points
- Interested in Millrose Properties, Inc.? Here are five stocks we like better.
- Strong second-quarter performance: Millrose reported adjusted funds from operations of $127.6 million
Legal & General Group H1 Earnings Call Highlights
Key Points
- Interested in Legal & General Group Plc? Here are five stocks we like better.
- Legal & General reported stronger first-half results, with core operating profit up 7% and core
Hiscox H1 Earnings Call Highlights
Key Points
- Interested in Hiscox Ltd? Here are five stocks we like better.
- Hiscox delivered strong first-half growth: gross written premium rose 10.1% to more than £3.2 billion, adjusted
Coca-Cola HBC Q2 Earnings Call Highlights
Key Points
- Interested in Coca-Cola HBC AG? Here are five stocks we like better.
- Strong first-half performance: Organic revenue increased 9.6%, driven by 7.5% volume growth, while comparable
Is Schwab International Core Equity (SICNX) a Strong Mutual Fund Pick Right Now?
On the lookout for a Non US - Equity fund? Starting with Schwab International Core Equity (SICNX) is one possibility. SICNX carries a Zacks Mutual Fund Rank of 1 (Strong Buy), which is based on
Is BNY Mellon SC Stock Index Inv (DISSX) a Strong Mutual Fund Pick Right Now?
Looking for a Small Cap Blend fund? You may want to consider BNY Mellon SC Stock Index Inv (DISSX) as a possible option. DISSX has no Zacks Mutual Fund Rank, but we have been able to look into other
Is PIMIX a Strong Bond Fund Right Now?
There are plenty of choices in the Diversified Bonds category, but where should you start your research? Well, one fund that might be worth investigating is PIMCO Income Institutional (PIMIX). PIMIX
Recursion Pharmaceuticals (RXRX) Reports Q2 Loss, Misses Revenue Estimates
Recursion Pharmaceuticals (RXRX) came out with a quarterly loss of $0.25 per share versus the Zacks Consensus Estimate of a loss of $0.23. This compares to a loss of $0.41 per share a year ago
Zimmer Biomet (ZBH) Q2 Earnings and Revenues Beat Estimates
Zimmer Biomet (ZBH) came out with quarterly earnings of $2.07 per share, beating the Zacks Consensus Estimate of $2.01 per share. This compares to earnings of $2.07 per share a year ago. These
NCR Voyix (VYX) Q2 Earnings and Revenues Top Estimates
NCR Voyix (VYX) came out with quarterly earnings of $0.17 per share, beating the Zacks Consensus Estimate of $0.15 per share. This compares to earnings of $0.19 per share a year ago. These figures
Utz Brands (UTZ) Q2 Earnings Match Estimates
Utz Brands (UTZ) came out with quarterly earnings of $0.19 per share, in line with the Zacks Consensus Estimate . This compares to earnings of $0.17 per share a year ago. These figures are adjusted
United Therapeutics (UTHR) Q2 Earnings Surpass Estimates
United Therapeutics (UTHR) came out with quarterly earnings of $7.27 per share, beating the Zacks Consensus Estimate of $6.82 per share. This compares to earnings of $6.41 per share a year ago